Introduction {#Sec1}
============

Although surgical site infection (SSI) after thyroid surgery is uncommon, it may lead to further complications and increased healthcare cost \[[@CR1]--[@CR3]\].

The frequency of SSI after thyroid surgery has been estimated to be 0.3--2.9% \[[@CR1], [@CR4]--[@CR8]\].

Surgical site infection may manifest as wound cellulitis and treated with oral antibiotics or as infected seroma which may require drainage and culture-directed treatment with intravenous antibiotics \[[@CR9]\].

In studies published during the last two decades, prolonged operation time, use of drains, reoperation due to bleeding and concomitant lymph node dissection have been reported as risk factors for SSI in thyroid surgery \[[@CR1], [@CR4], [@CR10], [@CR11]\].

The use of preoperative antibiotic prophylaxis is generally not recommended due to the low incidence of SSI after thyroid surgery \[[@CR1], [@CR12]--[@CR14]\]. However, in practice this routine varies \[[@CR15], [@CR16]\]. Whether or not there is a subgroup of patients with higher risk of SSI where prophylactic antibiotics could be considered is at present unclear. Results from a multicentre retrospective observational study on 2926 patients who had underwent thyroid surgery showed that antibiotic prophylaxis did not decrease the incidence of SSI \[[@CR17]\].

In a single-centre randomized clinical trial (RCT), Uruno et al. \[[@CR13]\] showed that antibiotic prophylaxis did not protect the patient from SSI in thyroid surgery. However, all patients with reported SSI had post-operative drains and underwent lymph node dissection, with one exception.

This retrospective multicentre study, therefore, aimed to investigate risk factors for SSI and the effect of antibiotic prophylaxis in a national cohort of operated patients undergoing thyroid surgery. Data were registered in the national quality register for endocrine surgery, and additional information was queried from attending surgeons by questionnaires. The course of treatment of patients with SSI is also described.

Methods {#Sec2}
=======

Scandinavian quality register for thyroid, parathyroid and adrenal surgery {#Sec3}
--------------------------------------------------------------------------

Data were collected from the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery (SQRTPA), which is the recognized quality register in this medical field in Sweden. The registry is endorsed by the Swedish Association of Endocrine Surgeons and Swedish Association of Otorhinolaryngology and Head and Neck Surgery. Data are registered prospectively by the attending surgeons.

Operations performed for thyroid disease registered in the database 2004--2010 were included in the study. Data were extracted from the registry in March 2012.

Surgical site infection (SSI) was defined as a local wound complication registered in SQRPTA by the attending surgeon.

Matching cohort {#Sec4}
---------------

Since some additional information, among those ongoing medication, the use of antibiotic prophylaxis, co-morbidities, body mass index, smoking habits, the use of drain and the course of treatment for SSI were not registered in SQRTPA, patients with SSI were matched 1:1 by age and gender to controls. This additional information was queried by questionnaire, which was sent to the attending surgeons in 27 departments. Data from the questionnaires were collected and merged with the data from SQRTPA for further analysis. Through the same questionnaire, it was confirmed that data entry in the SQRTPA was correct.

Analysis {#Sec5}
--------

Two different types of analyses were performed.Patients with SSI were compared with patients without SSI in the SQRTPA cohort in order to assess the impact of age and gender as risk factors.Patients with SSI were analysed to controls matched 1:1 as a nested case--control study to evaluate additional possible risk factors for SSI which were not available in the SQRTPA.Patients with independent risk factors for SSI in the multivariable analysis in the case--control cohort were analysed regarding the use of antibiotic prophylaxis.

Statistics {#Sec6}
----------

Risk factors for patients with SSI were evaluated using univariable and multivariable logistic regression and presented as odds ratio (OR) and 95% confidence interval (CI). Continuous variables are reported as median and interquartile range (IQR) and analysed using Wilcoxon rank-sum test. Categorical variables were analysed using Chi-square test.

A *p* value \< 0.05 was considered significant.

Variables with *p* \< 0.10 and with missing values less than 50% (age, gender, indication for operation, lymph node dissection, post-operative bleeding, operation time, specimen weight, drainage and diabetes) were included in the multivariable logistic regression model.

For the statistical analysis, STATA/IC version 12.0 was used.

Ethical issues {#Sec7}
--------------

The study was approved by the regional ethical committee for clinical trials (DNR 2011/740).

Results {#Sec8}
=======

During the study period, 9494 operations were registered. A total of 236 (2.5%) patients were operated with compartment-oriented lymph node dissection only. Surgical site infection was reported in 109 (1.2%) patients. All 109 patients with SSI were successfully matched with control patients from the cohort. The response rate for the questionnaire was 96% (210 answers out of 218 sent questionnaires).

Patients with and without surgical site infection in the total cohort {#Sec9}
---------------------------------------------------------------------

Patients with SSI were older with a median (IQR) age of 53 (41--65) versus 49 (37--62) years compared with patients without SSI, *p* = 0.01, and more often had a histological diagnosis of malignancy 23 (21.1%) versus 1137 (12.1%), respectively, *p* = 0.01. Patients with SSI were more often subjected to lymph node dissection 40 (36.7%) versus 1453 (15.3%), *p* \< 0.01, and had a higher incidence of post-operative bleeding 7 (6.5%) versus 167 (1.8%), *p* \< 0.01. Patients with SSI also had a higher median specimen weight of 65 g (24--125) versus 37 g (20--82) *p* = 0.02 and a somewhat increased risk for an operation time of more than 120 min 40 (36.7%) versus 2945 (31.4%) in control patients, although missing values for operation time have to be accounted for *p* \< 0.01 (Table [1](#Tab1){ref-type="table"}).Table 1Clinical characteristics of patients registered in the Swedish National Registry for Endocrine Surgery, with and without post-operative surgical site infectionCharacteristicsNo SSI\
*n* = 9385 (%)SSI\
*n* = 109 (%)*P* valueAge *Median/IQR49/37*--*6253/41*--*65*0.01Gender Male1804 (19.2)29 (26.6)0.05 Female7581 (80.8)80 (73.4)Indication for operation Compression symptom3627 (38.6)47 (43.1)0.01 Malignancy1137 (12.1)23 (21.1) Excluding malignancy2290 (24.4)20 (18.3) Thyrotoxicosis2220 (23.7)17 (15.6) Other(\*)111 (1.2)2 (1.8)Type of operation Total thyroidectomy3944 (42.0)43 (39.5)0.70 Hemithyroidectomy4500 (48.0)54 (49.5) Other(\*\*)711 (7.6)6 (5.5) Missing value230 (2.4)6 (5.5)Lymph node dissection Yes1453 (15.3)40 (36.7)\<0.01 No7932 (83.5)69 (63.3)Reoperation due to post-operative bleeding Yes167 (1.8)7 (6.5)\<0.01 No9218 (98.2)102 (93.5)Operation time (min) \<60492(5.2)1(0.9)\<0.01 61--1203085(32.9)20(18.4) \>1202945(31.4)40(36.7) Missing value2863 (30.5)48 (44.0)Previous thyroid surgery Yes1053 (11.2)13 (11.9)0.82 No8332 (88.8)96 (88.0)Specimen weight (g) *Median/IQR37/20*--*8265/24*--*125*0.02 Missing value2522 (26.9)42 (38.5)Substernal gland Yes798 (8.5)14 (12.8)0.10 No8587 (91.5)95 (87.2)Data are reported in percentage for categorical variables and median (interquartile range) for quantitative onesMedian/IQR is presented in italics*SSI* surgical site infection, *IQR* interquartile range(\*) Unknown indication registered(\*\*) Include unilateral and bilateral resections of the thyroid gland

The multivariable logistic regression showed that lymph node dissection, OR 4.10 (95% CI 1.88--8.91), *p* \< 0.01, was an independent risk factor for SSI (Table [2](#Tab2){ref-type="table"}).Table 2Multivariable analysis of risk factors for surgical site infection in patients registered in the Swedish National Registry for Endocrine SurgeryVariablesOdds ratioConfidence interval*P* valueAge (year)1.011.00--1.030.05Gender Female1.00 Male1.120.63--2.010.68Indication for operation Compression symptoms1.00 Malignancy0.470.18--1.220.12 Excluding malignancy0.390.17--0.880.02 Thyrotoxicosis0.940.49--1.790.85Lymph node dissection No1.00 Yes4.101.88--8.91\<0.01Post-operative bleeding No1.00 Yes2.240.68--7.320.18Operation time (min) \<601.00 61--1201.880.23--13.870.56 \>1203.340.44--25.160.24 Missing3.190.04--24.210.26Specimen weight (g)1.000.99--1.000.61

Nested case--control analysis of patients with surgical site infection compared to controls.

After matching for gender and age, patients with SSI were more often operated due to malignancy 23 (21.1%) versus 8 (7.3%) patients among controls, *p* = 0.03, and more often underwent concomitant lymph node dissection 40 (36.7%) versus 14 (13.0%) patients, *p* \< 0.01. Patients with SSI were also more often treated with post-operative drains 68 (62.4%) versus 46 (42.2%) patients, *p* = 0.01 (Table [3](#Tab3){ref-type="table"}).Table 3Clinical characteristics of the patients with surgical site infection and control patients using data from Swedish National Registry for Endocrine Surgery and questionnaire data from participating departmentsCharacteristicsSSI\
*n* = 109 (%)Controls\
*n* = 109 (%)*P* valueAge *Median/IQR53/41*--*6553/41*--*65*1.00Gender Male29 (26.6)29 (26.6)1.00 Female80 (73.4)80 (73.4)Indication for surgery Compression symptoms47 (43.1)53 (48.6)0.03 Malignancy23 (21.1)8 (7.3) Excluding malignancy20 (18.3)19 (17.4) Thyrotoxicosis17 (15.6)28 (25.7) Other2 (1.8)1 (0.9)Type of operation Total thyroidectomy43 (39.5)46 (42.2)0.30 Hemithyroidectomy54 (49.5)56 (51.3) Other6 (5.5)4 (3.7) Missing value6 (5.5)3 (2.8)Lymph node dissection Yes40 (36.7)14 (13.0)\<0.01 No69 (63.3)95 (87.0)Previous thyroid surgery Yes13 (12.0)13 (12.0)1.00 No96 (88.0)96 (88.0)Operation time (min)0.03 \<601(0.9)5(4.6) 61--12020(18.4)34(31.2) \>12040(36.7)36(33.0)Missing value48 (44.0)34 (31.2)Specimen weight (g)*65/24*--*12554.5/26*--*123* Missing value42 (38.5)26 (29.0)0.93Substernal goitre Yes14 (12.8)15 (13.6)0.84 No95 (87.2)94 (86.4)Reoperation due to post-operative bleeding Yes7 (6.4)2 (1.8)0.09 No102 (93.6)107 (98.2)Cortisone medication\* Yes4 (3.6)6 (5.4)0.12 No99 (91.0)89 (81.6) Missing value6 (5.4)14 (13.0)Prophylactic antibiotics Yes3 (2.8)6 (5.5)0.50 No75 (69.0)94 (86.2) Missing value31 (28.2)9 (8.3)Diabetes Yes9 (8.3)2 (1.8)0.06 No95 (87.0)98 (89.9) Missing value5 (4.7)9 (8.2)Drainage Yes68 (62.4)46 (42.2)0.01 No34 (31.2)56 (51.4) Missing7 (6.4)7 (6.4)BMI*27/23*--*2926/23*--*29* Missing value79 (72.4)46 (42.2)0.88Smoker or ex-smoker Yes10(9.1)14(12.8)0.02 No18(16.5)33(30.2) Missing value81(74.4)62(57.0)Data are reported in percentage for categorical variables and median (interquartile range) for quantitative onesMedian/IQR is presented in italics*SSI* surgical site infection, *BMI* body mass index, *IQR* interquartile range\*Cortisone medication was defined as cortisone treatment before the patient was referred for surgery

In the multivariable logistic regression analysis of risk factors for SSI in the matched case--control cohort, lymph node dissection OR 3.22 (95% CI 1.32--7.82) and the use of drains OR 1.82 (95% CI 1.04--3.18) were independent risk factors for SSI (Table [4](#Tab4){ref-type="table"}).Table 4Multivariable analysis comparing patients with surgical site infection and control patients using data from Swedish National Registry for Endocrine Surgery and questionnaire data from participating departmentsVariablesOdds ratioConfidence intervalThyroidectomy1.00Lymph node dissection with or without thyroidectomy3.221.32--7.82Benign histology1.00Malignancy1.250.40--3.91Post-operative drainage No1.00 Yes1.821.04--3.18Diabetes mellitus No1.00 Yes0.550.29--1.04Operation time (min) \<601.0 61--1202.220.23--21.24 \>1203.760.40--34.82 Missing value4.630.50--42.78Post-operative bleeding No1.00 Yes3.340.59--18.83

Diagnosis and treatment of surgical site infection {#Sec10}
--------------------------------------------------

The attending surgeon reported that 30 (27%) patients with SSI were diagnosed before discharge from the hospital whereas 53 (49%) patients were diagnosed after the date of discharge. Data were missing for 26 (24%) patients regarding when SSI was diagnosed. Among patients with SSI, 78 (72%) patients were treated with antibiotics, 3 (2%) patients did not receive antibiotics and data were missing for 28 (26%) patients. Readmission in the hospital due to SSI was reported in 36 (33%) patients.

Data from the case--control cohort showed that among the 34 patients with independent risk factors for SSI (i.e. lymph node dissection and post-operative drain) 26 (76%) patients had SSI. Since the use of drain was missing for the rest of cohort, a comparison between patients with SSI and the rest of cohort was not possible. Only 2 (8%) out of the 26 patients were treated with antibiotics prophylactically, whereas 16 (62%) patients did not receive prophylactic antibiotics. Data regarding antibiotic prophylaxis were missing in 8 (31%) patients (*p* = 0.12).

Discussion {#Sec11}
==========

This study of a national cohort of 9494 patients who underwent surgery for thyroid disease reports a low risk of SSI, 1.2%.

Concomitant lymph node dissection and the use of drains were independent risk factors for SSI after thyroid surgery.

A previous study on complications after thyroid surgery using data from SQRTPA showed that patients who underwent lymph node dissection and were reoperated due to bleeding had increased risk of SSI \[[@CR4]\]. The present study included data from three times more patients, and additional information from the attending surgeons, which enabled a nested case--control analysis to be performed. In the present study, lymph node dissection was verified as an independent risk factor for SSI. Additionally, the use of prophylactic drainage was proved to be an independent risk factor. However, reoperation for post-operative bleeding was not a risk factor.

A recent meta-analysis has shown that the use of drain in thyroid surgery is associated with high rate of SSI, prolonged hospital stay and a high pain score \[[@CR18]--[@CR20]\]. Drains neither prevented post-operative bleeding nor did they facilitate early diagnosis of bleeding \[[@CR10], [@CR19], [@CR20]\]. In agreement, the present study showed that the use of drain in thyroid surgery increased the risk of SSI. The use of drains in other areas with low risk of post-operative infection, such as breast surgery, has also been associated with a higher risk of SSI \[[@CR21]\]. Therefore, the use of drain in routine thyroid surgery should be discouraged.

Surgical site infection after modified radical neck dissection due to cancer in the neck is a major complication estimated to occur in 13--20% of patients undergoing this procedure \[[@CR22], [@CR23]\]. The reason for this is not clear, but could be due to prolonged operation time or the lymph node dissection per se. It might be considered that lymph node dissection may cause disruption to the immune system and reduce the local barrier for infection.

In a previous investigation, Bures et al. \[[@CR1]\] found that the duration of operation was an independent risk factor for SSI in thyroid surgery. The duration of operation was, however, not significant in the multivariable analysis in the present investigation. It is therefore likely that the duration of operation is a dependent risk factor due to the time required for lymph node dissection.

Lymph node dissection and the use of drain were associated with higher incidence of SSI, and it may be argued that prophylactic antibiotics may reduce the risk of SSI in these patients. Results from a national multicentre retrospective observational study by De Palma et al. \[[@CR17]\] and a randomized controlled trial by Uruno et al. \[[@CR13]\] showed that antibiotic prophylaxis did not protect the patient from SSI in thyroid surgery. However, in the study done by De Palma it was not reported if the patients were subjected to concomitant lymph node dissection or not. In the single-centre RCT, all patients with reported SSI had post-operative drains and underwent lymph node dissection, with one exception.

The results from the questionnaire data showed that 26 patients with SSI were subjected to drains and lymph node dissection, 16 (62%) patients did not receive prophylactic antibiotics. Only 2 (8%) of patients with the two independent risk factors for SSI and diagnosed with SSI had prophylactic antibiotic treatment. Information about prophylactic antibiotics was missing for 8 (31%) patients. This difference, however, was not significant, possibly due to too few observations.

The strength of the present study is the large number of patients and that data are based on a national data set, SQRTPA, which at present covers over 90% of the thyroid operations in Sweden \[[@CR24]\].

Some limitations of the current study are acknowledged. This nested case--control study was retrospective, per se, although identification of patients with SSI was based on registration of data in the SQRTPA. There were missing data for some variables, e.g. antibiotic prophylaxis, which may hamper analysis and the interpretation of the results. Further, in the analysis, it was not possible to differentiate between central and lateral lymph node dissections, since these data were available only for the latter part of the study period.

Accordingly, due to the low incidence of SSI in thyroid surgery it might be helpful to evaluate the effect of antibiotic prophylaxis in subgroups with independent risk factors rather than evaluating this effect in the whole cohort. It could be considered that subgroup of patients with independent risk factors might benefit from prophylactic antibiotics in thyroid surgery.

Conclusion {#Sec12}
==========

The use of drains and concomitant lymph node dissection are associated independently with SSI in surgery for thyroid disease. Patients with these two risk factors constitute a subgroup in which prophylactic antibiotics might be considered. The use of drains in routine non-malignant thyroid surgery should be discouraged.
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